LUCA REPORT

Component: (Network and Hypercube)
Network	0001 - Statement - Assets (http://someinsurancecompany.com/report/role/BlankAssets)
Hypercube	Assets [Hypercube]

Reporting Entity [Aspect]	TestData \| http://www.example.com
Unit [Aspect]	iso4217:USD

Concept [Aspect]	Period [Aspect]
	2022-12-31			2021-12-31
	Admitted [Dimension]			Admitted [Dimension]
	Admitted [Member]	Nonadmitted [Member]	Net Admitted [Member]	Admitted [Member]	Nonadmitted [Member]	Net Admitted [Member]
1. Bonds (Schedule D)	$ 1,000,000	$ 0	$ 1,000,000			$ 1,000,000
2. Stocks (Schedule D):
2.1 Preferred stocks	$ 1,000,000	$ 0	$ 1,000,000			$ 1,000,000
2.2 Common stocks	1,000,000	0	1,000,000			1,000,000
3. Mortgage loans on real estate (Schedule B):
3.1 First liens	$ 1,000,000	$ 0	$ 1,000,000			$ 1,000,000
3.2 Other than first liens	1,000,000	0	1,000,000			1,000,000
4. Real estate (Schedule A):
4.1 Properties occupied by the company	$ 1,000,000	$ 0	$ 1,000,000			$ 1,000,000
4.2 Properties held for the production of income	1,000,000	0	1,000,000			1,000,000
4.3 Properties held for sale	1,000,000	0	1,000,000			1,000,000
5. Cash, cash equivalents, and short-term investments	$ 1,000,000	$ 0	$ 1,000,000			$ 1,000,000
6. Contract loans	1,000,000	0	1,000,000			1,000,000
7. Derivatives (Schedule DB)	1,000,000	0	1,000,000			1,000,000
8. Other invested assets (Schedule BA)	1,000,000	0	1,000,000			1,000,000
9. Receivables from securities	1,000,000	0	1,000,000			1,000,000
10. Securities lending reinvested collateral assets (Schedule DL)	1,000,000	0	1,000,000			1,000,000
11. Aggregate write-ins for invested assets	1,000,000	0	1,000,000			1,000,000
12. Subtotals, cash and invested assets (Lines 1 to 11)	15,000,000	0	15,000,000			15,000,000
13. Title plants (for title insurers only)	1,000,000	0	1,000,000			1,000,000
14. Investment income due and accrued	1,000,000	0	1,000,000			1,000,000
15. Premiums and considerations
15.1 Uncollected premiums and agents' balances in the course of collection	$ 1,000,000	$ 0	$ 1,000,000			$ 1,000,000
15.2 Deferred premiums, agents' balances and installments booked but deferred and not yet due including earned but unbilled premiums	1,000,000	0	1,000,000			1,000,000
15.3 Accrued retrospective premiums contracts subject to remediation	1,000,000	0	1,000,000			1,000,000
16. Reinsurance:
16.1 Amounts recoverable from reinsurers	1,000,000	0	1,000,000			1,000,000
16.2 Funds held by or deposited with reinsured companies	1,000,000	0	1,000,000			1,000,000
16.3 Other amounts receivable under reinsurance contracts	1,000,000	0	1,000,000			1,000,000
17. Amounts receivable related to uninsured plans	1,000,000	0	1,000,000			1,000,000
18.1 Current federal and foreign income tax recoverable and interest thereon	1,000,000	0	1,000,000			1,000,000
18.2 Net deferred tax asset	1,000,000	0	1,000,000			1,000,000
19. Guaranty funds receivable or on deposit	1,000,000	0	1,000,000			1,000,000
20. Electronic data processing equipment and software	1,000,000	0	1,000,000			1,000,000
21. Furniture and equipment, including health care delivery assets	1,000,000	0	1,000,000			1,000,000
22. Net adjustment in assets and liabilities do to foreign exchange rates	1,000,000	0	1,000,000			1,000,000
23. Receivable from parent, subsidiaries and affiliates	1,000,000	0	1,000,000			1,000,000
24. Health care and other amounts receivable	1,000,000	0	1,000,000			1,000,000
25. Aggregate write-ins for other-than-invested assets	1,000,000	0	1,000,000			1,000,000
26. Total assets excluding seperate accounts, Segregated Accounts and Protected Cell Accounts	33,000,000	0	33,000,000			33,000,000
27. From Separate Accounts, Segregated Accounts and Protected Cell Accounts	1,000,000	0	1,000,000			1,000,000
28. Total (Lines 26 and 27)	$ 34,000,000	$ 0	$ 34,000,000			$ 34,000,000
Parenthetical
Encumbrances on properties occupied	$ 0	$ 0	$ 0			$ 0
Encumbrances on properties held for the production of income	0	0	0			0
Encumbrances on properties held for sale	0	0	0			0
Cash	0	0	0			0
Cash equivalents	1,000,000	0	1,000,000			1,000,000
Short-term investments	0	0	0			0
Premium notes included in contract loans	0	0	0			0
Title plant charged off	0	0	0			0
Earned but unbilled premiums	0	0	0			0
DETAILS OF WRITE-INS
1101. Custom Item 1101	0	0	0			0
1102. Custom Item 1102	0	0	0			0
1103. Custom Item 1103	0	0	0			0
1198. Summary of Remaining Write-ins for Line 11 from overflow page	0	0	0			0
1199. Total (Lines 1101 through 1103 plus 1198) (Line 11 above)	$ 0	$ 0	$ 0			$ 0
2501. Custom Item 2501	0	0	0			0
2502. Custom Item 2502	0	0	0			0
2503. Custom Item 2503	0	0	0			0
2598. Summary of remaining write-ins for Line 25 from overflow page	0	0	0			0
2599. Total (Lines 2501 through 2503 plus 2598) (Line 25 above)	$ 0	$ 0	$ 0			$ 0

Component: (Network and Hypercube)
Network	0002 - LIABILITIES, SURPLUS AND OTHER FUNDS (http://someinsurancecompany.com/report/role/P2023LIAB)
Hypercube	Liabilities and Surplus [Hypercube]

Reporting Entity [Aspect]	TestData \| http://www.example.com
Unit [Aspect]	iso4217:USD

Concept [Aspect]	Period [Aspect]
Concept [Aspect]	2022-12-31	2021-12-31	2020-12-31
LIABILITIES AND SURPLUS [Abstract]
LIABILITIES [Abstract]
1. Losses (Part 2A, Line 35, Column 8)	$ 0	$ 0
2. Reinsurance payable on paid losses and loss adjustment expenses (Schedule F, Part 1, Column 6)	0	0
3. Loss adjustment expenses (Part 2A, Line 35, Column 9)	0	0
4. Commissions payable, contingent commissions and other similar charges	0	0
5. Other expenses (excluding taxes, licenses and fees)	0	0
6. Taxes, licenses and fees (excluding federal and foreign income taxes)	0	0
7.1 Current federal and foreign income taxes (including $………. on realized capital gains (losses))	0	0
7.2 Net deferred tax liability	0	0
8. Borrowed money $………and interest thereon $	0	0
9. Unearned premiums (Part 1A, Line 38, Column 5)	0	0
10. Advance premium	0	0
11. Dividends declared and unpaid:	0	0
11.1 Stockholders	0	0
11.2 Policyholders	0	0
12. Ceded reinsurance premiums payable (net of ceding commissions)	0	0
13. Funds held by company under reinsurance treaties (Schedule F, Part 3, Column 20)	0	0
14. Amounts withheld or retained by company for account of others	0	0
15. Remittances and items not allocated	0	0
16. Provision for reinsurance (including $ certified) (Schedule F, Part 3 Column 78)	0	0
17. Net adjustments in assets and liabilities due to foreign exchange rates	0	0
18. Drafts outstanding	0	0
19. Payable to parent, subsidiaries and affiliates	0	0
20. Derivatives	0	0
21. Payable for securities	0	0
22. Payable for securities lending	0	0
23. Liability for amounts held under uninsured plans	0	0
24. Capital notes $………………..and interest thereon $………………	0	0
25. Aggregate write-ins for liabilities	0	0
26. Total liabilities excluding protected cell liabilities (Lines 1 through 25)	0	0
27. Protected cell liabilities	0	0
28. Total liabilities (Lines 26 and 27)	0	0
xx. Surplus [Abstract]
29. Aggregate write-ins for special surplus funds	0	0
30. Common capital stock	0	0
31. Preferred capital stock	0	0
32. Aggregate write-ins for other-than-special surplus funds	0	0
33. Surplus notes	0	0
34. Gross paid in and contributed surplus	0	0
35. Unassigned funds (surplus)	0	0
36. Less treasury stock, at cost:	0	0
36.1 ………….. shares common (value included in Line 30 $………………..)	0	0
36.2 ………….. shares preferred (value included in Line 31 $………………..)	0	0
37. Surplus as regards policyholders (Lines 29 to 35, less 36) (Page 4, Line 39)	0	0	0
38. Totals (Page 2, Line 28, Col. 3)	$ 0	$ 0

Component: (Network and Hypercube)
Network	0003 - STATEMENT OF INCOME (http://someinsurancecompany.com/report/role/P2023STMTINCOME)
Hypercube	Statement of Income [Hypercube]

Reporting Entity [Aspect]	TestData \| http://www.example.com
Unit [Aspect]	iso4217:USD

Concept [Aspect]	Period [Aspect]
Concept [Aspect]	2022-01-01 \| 2022-12-31	2021-01-01 \| 2021-12-31
Net income [Roll Up]
Net income before tax [Roll Up]
Net income before dividends [Roll Up]
1. Premiums earned (Part 1, Line 35, Column 4)	$ 0
DEDUCTIONS:
2. Losses incurred (Part 2, Line 35, Column 7)	$ 0
3. Loss adjustment expenses incurred (Part 3, Line 25, Column 1)	0
4. Other underwriting expenses incurred (Part 3, Line 25, Column 2)	0
5. Aggregate write-ins for underwriting deductions	0
6. Total underwriting deductions (Lines 2 through 5)	0
UNDERWRITING INCOME:
7. Net income of protected cells	0
8. Net underwriting gain (loss) (Line 1 minus Line 6 plus Line 7)	0
INVESTMENT INCOME:
9. Net investment income earned (Exhibit of Net Investment Income, Line 17)	0
10. Net realized capital gains (losses) less capital gains tax of $……….(Exhibit of Capital Gains (Losses))	0
11. Net investment gain (loss) (Lines 9 + 10)	0
OTHER INCOME:
12. Net gain (loss) from agents' or premium balances charged off (amount recovered $ amount charged off $)	0
13. Finance and service charges not included in premiums	0
14. Aggregate write-ins for miscellaneous income	0
15. Total other income (Lines 12 through 14)	0
16. Net income before dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes (Lines 8+11+15)	0
17. Dividends to policyholders	0
18. Net income, after dividends to policyholders, after capital gains tax and before all other federal and foreign income taxes (Line 16 minus Line 17)	0
19. Federal and foreign income taxes incurred	0
20. Net income (Line 18 minus Line 19) (to Line 22)	$ 0	$ 1,000,000

Component: (Network and Hypercube)
Network	0004 - Statement of Changes in Surplus (http://someinsurancecompany.com/report/role/StatementOfChangesInSurplus)
Hypercube	Statement of Changes in Surplus [Hypercube]

Reporting Entity [Aspect]	TestData \| http://www.example.com
Unit [Aspect]	iso4217:USD

Concept [Aspect]	Period [Aspect]
Concept [Aspect]	Period [Aspect]
CAPITAL AND SURPLUS ACCOUNT
21. Surplus as regards policyholders, Beginning	2021-12-31	$ 0	2020-12-31	$ 0
20. Net income (Line 18 minus Line 19) (to Line 22)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	1,000,000
23. Net transfers (to) from Protected Cell accounts	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
24. Change in net unrealized capital gains or (losses) less capital gains tax of $	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
25. Change in net unrealized foreign exchange capital gain (loss)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
26. Change in net deferred income tax	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
27. Change in nonadmitted assets (Exhibit of Nonadmitted Assets, Line 28, Col. 3)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
28. Change in provision for reinsurance (Page 3, Line 16, Column 2 minus Column 1)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
29. Change in surplus notes	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
30. Surplus (contributed to) withdrawn from protected cells	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
31. Cumulative effect of changes in accounting principles	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
32. Capital changes:
32.1 Paid in	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
32.2 Transferred from surplus (Stock Dividend)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
32.3 Transferred to surplus	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
33. Surplus adjustments:
33.1 Paid in	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
33.2 Transferred to capital (Stock Dividend)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
33.3 Transferred from capital	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
34. Net remittances from or (to) Home Office	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
35. Dividends to stockholders	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
36. Change in treasury stock (Page 3, Lines 36.1 and 36.2, Column 2 minus Column 1)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
37. Aggregate write-ins for gains and losses in surplus	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
38. Change in surplus as regards policyholders for the year (Lines 22 through 37)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
28. Surplus as regards policyholders, Ending	2022-12-31	$ 0	2021-12-31	$ 0

Component: (Network and Hypercube)
Network	0005 - CASH FLOW (http://someinsurancecompany.com/report/role/P2023CASH)
Hypercube	Statement of Cash Flow [Hypercube]

Reporting Entity [Aspect]	TestData \| http://www.example.com
Unit [Aspect]	iso4217:USD

Concept [Aspect]	Period [Aspect]
Concept [Aspect]	Period [Aspect]
CASH FLOW
Cash from operations
1. Premiums collected net of reinsurance	2022-01-01 \| 2022-12-31	$ 0	2021-01-01 \| 2021-12-31	$ 0
2. Net investment income	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
3. Miscellaneous income	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
4. Total (Lines 1 through 3)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
5. Benefit and loss related payments	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
6. Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
7. Commissions, expenses paid and aggregate write-ins for deductions	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
8. Dividends paid to policyholders	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
9. Federal and foreign income taxes paid (recovered) net of $………. tax on capital gains (losses)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
10. Total (Lines 5 through 9)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
11. Net cash from operations (Line 4 minus Line 10)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
12.1 Bonds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.2 Stocks	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.3 Mortgage loans	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.4 Real estate	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.5 Other invested assets	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.6 Net gains or (losses) on cash, cash equivalents and short-term investments	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.7 Miscellaneous proceeds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.8 Total investment proceeds (Lines 12.1 to 12.7)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13. Cost of investments acquired (long-term only):	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.1 Bonds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.2 Stocks	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.3 Mortgage loans	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.4 Real estate	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.5 Other invested assets	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.6 Miscellaneous applications	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.7 Total investments acquired (Lines 13.1 to 13.6)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
14. Net increase/(decrease) in contract loans and premium notes	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
15. Net cash from investments (Line 12.8 minus Line 13.7 minus Line 14)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
Cash from Financing and Miscellaneous Sources
16. Cash provided (applied):
16.1 Surplus notes, capital notes	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.2 Capital and paid in surplus, less treasury stock	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.3 Borrowed funds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.4 Net deposits on deposit-type contracts and other insurance liabilities	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
35. Dividends to stockholders	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.6 Other cash provided (applied)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
17. Net cash from financing and miscellaneous sources (Lines 16.1 to 16.4 minus Line 16.5 plus Line 16.6)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
18. Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
19. Cash, cash equivalents and short-term investments:
Beginning	2021-12-31		2020-12-31
Ending	2022-12-31		2021-12-31

Component: (Network and Hypercube)
Network	0006 - Assets - Bonds - Schedule D (http://someinsurancecompany.com/report/role/ScheduleD)
Hypercube	Schedule D [Hypercube]

Reporting Entity [Aspect]

TestData | http://www.example.com

Concept [Aspect]	Units	Period [Aspect]
		2003-01-01 \| 2003-12-31			2003-12-31
		CUSIP [Dimension]			CUSIP [Dimension]
		CUSIP 0000001 [Member]	CUSIP 0000002 [Member]	All CUSIPs [Member]	CUSIP 0000001 [Member]	CUSIP 0000002 [Member]	All CUSIPs [Member]
CUSIP [Set]
Description		Description of CUSIP 0000001	Description of CUSIP 0000002
Code		CODE1	CODE2
Foreign		asdf	asdf
Bond CHAR					asdf	asdf
NAIC Designation					asdf	asdf
Actual Cost	iso4217:USD				1,000	2,000	3,000
Fair Value [Abstract]
Fair Value, Rate Used to Obtain Fair Value	Pure				1,000	2,000	0
Fair Value	iso4217:USD				1,000	2,000	0
Par Value	iso4217:USD				1,000	2,000	0
Book/Adjusted Carrying Value	iso4217:USD				1,000	2,000	0
Change in Book/Adjusted Carring Value [Abstract]
Unrealized Valuation Increase (Decrease)	iso4217:USD	100	100	0
Current Year's (Amortization) / Accretion	iso4217:USD	100	100	0
Current Year's Other-Than-Temporary Impairmeent Recognized	iso4217:USD	100	100	0
Total Foreign Exchange Change in B./A./C.V.	iso4217:USD	100	100	0
Interest [Abstract]
Rate of	Pure				0	0	1
Effective Rate of	Pure				0	0	1
When Paid					2023-12-31	2023-12-31	2003-12-15
Admitted Amount Due & Accrued	iso4217:USD				100	200	100
Amount Received During Year	iso4217:USD				100	200	100
Dates [Abstract]
Acquired					2023-12-31	2023-12-31
Stated Contractual Maturity Date					2023-12-31	2023-12-31

Concept [Aspect]	Period [Aspect]
Concept [Aspect]	Period [Aspect]
CAPITAL AND SURPLUS ACCOUNT
21. Surplus as regards policyholders, Beginning	2021-12-31	$ 0	2020-12-31	$ 0
20. Net income (Line 18 minus Line 19) (to Line 22)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	1,000,000
23. Net transfers (to) from Protected Cell accounts	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
24. Change in net unrealized capital gains or (losses) less capital gains tax of $	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
25. Change in net unrealized foreign exchange capital gain (loss)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
26. Change in net deferred income tax	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
27. Change in nonadmitted assets (Exhibit of Nonadmitted Assets, Line 28, Col. 3)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
28. Change in provision for reinsurance (Page 3, Line 16, Column 2 minus Column 1)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
29. Change in surplus notes	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
30. Surplus (contributed to) withdrawn from protected cells	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
31. Cumulative effect of changes in accounting principles	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
32. Capital changes:
32.1 Paid in	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
32.2 Transferred from surplus (Stock Dividend)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
32.3 Transferred to surplus	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
33. Surplus adjustments:
33.1 Paid in	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
33.2 Transferred to capital (Stock Dividend)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
33.3 Transferred from capital	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
34. Net remittances from or (to) Home Office	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
35. Dividends to stockholders	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
36. Change in treasury stock (Page 3, Lines 36.1 and 36.2, Column 2 minus Column 1)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
37. Aggregate write-ins for gains and losses in surplus	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
38. Change in surplus as regards policyholders for the year (Lines 22 through 37)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
28. Surplus as regards policyholders, Ending	2022-12-31	$ 0	2021-12-31	$ 0

Concept [Aspect]	Period [Aspect]
Concept [Aspect]	Period [Aspect]
CASH FLOW
Cash from operations
1. Premiums collected net of reinsurance	2022-01-01 \| 2022-12-31	$ 0	2021-01-01 \| 2021-12-31	$ 0
2. Net investment income	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
3. Miscellaneous income	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
4. Total (Lines 1 through 3)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
5. Benefit and loss related payments	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
6. Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
7. Commissions, expenses paid and aggregate write-ins for deductions	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
8. Dividends paid to policyholders	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
9. Federal and foreign income taxes paid (recovered) net of $………. tax on capital gains (losses)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
10. Total (Lines 5 through 9)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
11. Net cash from operations (Line 4 minus Line 10)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
12.1 Bonds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.2 Stocks	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.3 Mortgage loans	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.4 Real estate	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.5 Other invested assets	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.6 Net gains or (losses) on cash, cash equivalents and short-term investments	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.7 Miscellaneous proceeds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
12.8 Total investment proceeds (Lines 12.1 to 12.7)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13. Cost of investments acquired (long-term only):	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.1 Bonds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.2 Stocks	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.3 Mortgage loans	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.4 Real estate	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.5 Other invested assets	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.6 Miscellaneous applications	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
13.7 Total investments acquired (Lines 13.1 to 13.6)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
14. Net increase/(decrease) in contract loans and premium notes	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
15. Net cash from investments (Line 12.8 minus Line 13.7 minus Line 14)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
Cash from Financing and Miscellaneous Sources
16. Cash provided (applied):
16.1 Surplus notes, capital notes	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.2 Capital and paid in surplus, less treasury stock	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.3 Borrowed funds	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.4 Net deposits on deposit-type contracts and other insurance liabilities	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
35. Dividends to stockholders	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
16.6 Other cash provided (applied)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
17. Net cash from financing and miscellaneous sources (Lines 16.1 to 16.4 minus Line 16.5 plus Line 16.6)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
18. Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17)	2022-01-01 \| 2022-12-31	0	2021-01-01 \| 2021-12-31	0
19. Cash, cash equivalents and short-term investments:
Beginning	2021-12-31		2020-12-31
Ending	2022-12-31		2021-12-31